252 related articles for article (PubMed ID: 37793213)
1. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
[TBL] [Abstract][Full Text] [Related]
2. Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort.
Fan L; Zhu X; Borenstein AR; Huang X; Shrubsole MJ; Dugan LL; Dai Q
J Prev Alzheimers Dis; 2023; 10(3):513-522. PubMed ID: 37357292
[TBL] [Abstract][Full Text] [Related]
3. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
[TBL] [Abstract][Full Text] [Related]
4. Association of CSF GAP-43 and
Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
Park JI;
Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease.
Sohn D; Shpanskaya K; Lucas JE; Petrella JR; Saykin AJ; Tanzi RE; Samatova NF; Doraiswamy PM
Sci Rep; 2018 May; 8(1):7490. PubMed ID: 29748598
[TBL] [Abstract][Full Text] [Related]
7. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
[TBL] [Abstract][Full Text] [Related]
8. Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
Kling MA; Goodenowe DB; Senanayake V; MahmoudianDehkordi S; Arnold M; Massaro TJ; Baillie R; Han X; Leung YY; Saykin AJ; Nho K; Kueider-Paisley A; Tenenbaum JD; Wang LS; Shaw LM; Trojanowski JQ; Kaddurah-Daouk RF;
Alzheimers Dement; 2020 Sep; 16(9):1234-1247. PubMed ID: 32715599
[TBL] [Abstract][Full Text] [Related]
9. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.
Wang ML; Zou QQ; Sun Z; Wei XE; Li PY; Wu X; Li YH;
Alzheimers Res Ther; 2022 Dec; 14(1):185. PubMed ID: 36514127
[TBL] [Abstract][Full Text] [Related]
10. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
11. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
13. Multipredictor risk models for predicting individual risk of Alzheimer's disease.
Hou XH; Suckling J; Shen XN; Liu Y; Zuo CT; Huang YY; Li HQ; Wang HF; Tan CC; Cui M; Dong Q; Tan L; Yu JT;
J Transl Med; 2023 Oct; 21(1):768. PubMed ID: 37904154
[TBL] [Abstract][Full Text] [Related]
14. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
Kiselica AM; Benge JF;
Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
[TBL] [Abstract][Full Text] [Related]
16. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
Ren D; Lopez OL; Lingler JH; Conley Y
J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
[TBL] [Abstract][Full Text] [Related]
17. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
18. Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.
Thomas KR; Eppig JS; Weigand AJ; Edmonds EC; Wong CG; Jak AJ; Delano-Wood L; Galasko DR; Salmon DP; Edland SD; Bondi MW;
Alzheimers Dement; 2019 Apr; 15(4):561-569. PubMed ID: 30610833
[TBL] [Abstract][Full Text] [Related]
19. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
[TBL] [Abstract][Full Text] [Related]
20. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
